Status:
COMPLETED
Prospective Evaluation of a Commercially Available Hydrogel Spacer
Lead Sponsor:
BioProtect
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
Dosimetry efficacy evaluation of the hydrogel spacer
Detailed Description
Single arm study for evaluation of dosimetry following use of a commercially available hydrogel spacer implanted in 20 males undergoing radiotherapy to treat prostate cancer. Study will utilize pre an...
Eligibility Criteria
Inclusion
- Males
- At lease 18 years of age
- Undergoing external beam or brachy radiation therapy with a hydrogel spacer
Exclusion
- Invasive adenocarcinoma that is extracapsular and demonstrates posterior extension
Key Trial Info
Start Date :
November 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 8 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05323747
Start Date
November 20 2020
End Date
February 8 2022
Last Update
September 16 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Western Radiation Oncology
Campbell, California, United States, 95008
2
Northern Nevada Radiation Oncology
Reno, Nevada, United States, 89521